Suppr超能文献

生物医学研究中风险-效益评估的框架。

A framework for risk-benefit evaluations in biomedical research.

作者信息

Rid Annette, Wendler David

机构信息

Institute of Biomedical Ethics, University of Zurich.

出版信息

Kennedy Inst Ethics J. 2011 Jun;21(2):141-79. doi: 10.1353/ken.2011.0007.

Abstract

Essentially all guidelines and regulations require that biomedical research studies have an acceptable risk-benefit profile. However, these documents offer little concrete guidance for implementing this requirement and determining when it is satisfied. As a result, those charged with risk-benefit evaluations currently assess the risk-benefit profile of biomedical research studies in unsystematic ways, raising concern that some research participants are not being protected from excessive risks and that some valuable studies involving acceptable risk are being rejected. The present paper aims to address this situation by delineating the first comprehensive framework, which is based on existing guidelines and regulations as well as the relevant literature, for risk-benefit evaluations in biomedical research.

摘要

基本上所有的指导方针和法规都要求生物医学研究具有可接受的风险效益比。然而,这些文件对于如何落实这一要求以及如何判定何时达到要求几乎没有提供具体的指导。因此,目前负责风险效益评估的人员在评估生物医学研究的风险效益比时缺乏系统性,这引发了人们的担忧,即一些研究参与者没有得到充分保护,免受过度风险的侵害,而一些涉及可接受风险的有价值的研究却被拒绝。本文旨在通过勾勒首个全面框架来解决这一问题,该框架基于现有指导方针、法规以及相关文献,用于生物医学研究中的风险效益评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验